1. SOX2 is a promising predictor of relapse and death in advanced stage high-grade serous ovarian cancer patients with residual disease after debulking surgery. (1st November 2020) Authors: Bååth, Maria; Westbom-Fremer, Sofia; Martin de la Fuente, Laura; Ebbesson, Anna; Davis, Juliette; Malander, Susanne; Måsbäck, Anna; Kannisto, Päivi; Hedenfalk, Ingrid Journal: Molecular & cellular oncology Issue: Volume 7:Number 6(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗